Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spinal implant + robot rehab: a new hope for walking after injury?

NCT ID NCT02936453

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether a spinal implant that delivers electrical stimulation, combined with robot-assisted rehabilitation, can improve walking ability in people with chronic spinal cord injury. Participants will have a device implanted and then undergo months of training. The goal is to see if this approach is safe and can help them walk better and faster.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
spinal epidural electrical stimulation (EES) combined with robot-assisted rehabilitation
What this could lead to
If successful, this approach could help people with spinal cord injury walk better and faster, potentially improving independence and quality of life.
What could go wrong
This is an early, first-in-human study with a small number of participants, so success is not guaranteed. There are risks from surgery and device implantation, and the benefits may not be seen in all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jul 2016

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 (women or men) * Incomplete SCI graded as AIS A,B,C \& D * Level of lesion: T10 and above, based on AIS level determination by the PI, with preservation of conus function * The intact distance between the cone and the lesion must be at least 60mm * Focal spinal cord disorder caused by either trauma or epidural, subdural or intramedullary bleeding * Minimum 12 months post-injury * Completed in-patient rehabilitation program * Able to stand with walker or 2 crutches * Stable medical and physical condition as considered by Investigators * Adequate care-giver support and access to appropriate medical care in patient's home community * Agree to comply in good faith with all conditions of the study and to attend all required study training and visits * Must participate in two training sessions before enrolment * Must provide and sign Informed Consent prior to any study related procedures Exclusion Criteria: * Limitation of walking function based on accompanying (CNS) disorders (systemic malignant disorders, cardiovascular disorders restricting physical training, peripheral nerve disorders) * History of significant autonomic dysreflexia * Cognitive/brain damage * Epilepsy * Patient who has spinal canal stenosis * Patient who uses an intrathecal Baclofen pump. * Patient who has any active implanted cardiac device such as pacemaker or defibrillator. * Patient who has any indication that would require diathermy. * Patient who has any indication that would require MRI. * Patient that have an increased risk for defibrillation * Severe joint contractures disabling or restricting lower limb movements. * Haematological disorders with increased risk for surgical interventions (increased risk of haemorrhagic events). * Participation in another locomotor training study. * Congenital or acquired lower limb abnormalities (affection of joints and bone). * Women who are pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding or not willing to take contraception. * Known or suspected non-compliance, drug or alcohol abuse. * Spinal cord lesion due to either a neurodegenerative disease or a tumour. * Patient has other anatomic or co-morbid conditions that, in the investigator's opinion, could limit the patient's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results. * Patient is unlikely to survive the protocol follow-up period of 12 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Canton of Vaud, 1011, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.